These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11747950)

  • 21. Combining low-molecular-weight heparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: the NICE 3 story. National Investigators Collaborating on Enoxaparin.
    Ferguson JJ
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E10-3;discussion E25-8. PubMed ID: 11156723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet receptor glycoprotein IIb/IIIa inhibition with eptifibatide in a patient with thrombocytopenia after treatment with abciximab.
    Coto H
    J Invasive Cardiol; 2000 Oct; 12(10):528-31. PubMed ID: 11022214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial.
    Desch S; Wöhrle J; Hambrecht R; Rittger H; Birkemeyer R; Lauer B; Neuhaus P; Brosteanu O; Sick P; Pauschinger M; Kerber S; Kleinertz K; de Waha S; Eitel I; Schuler G; Thiele H
    J Am Coll Cardiol; 2013 Sep; 62(13):1214-5. PubMed ID: 23850911
    [No Abstract]   [Full Text] [Related]  

  • 24. Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Ernst NM; Suryapranata H; Miedema K; Slingerland RJ; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; de Boer MJ; Zijlstra F; van 't Hof AW
    J Am Coll Cardiol; 2004 Sep; 44(6):1187-93. PubMed ID: 15364318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [ASSENT III and GUSTO V: is it the end of combination therapy with GPIIb/IIIa blockers and thrombolytics in myocardial infarction?].
    Vahanian A
    Ann Cardiol Angeiol (Paris); 2002 Jan; 51(1):6-7. PubMed ID: 12471654
    [No Abstract]   [Full Text] [Related]  

  • 26. Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role?
    Mukherjee D; Roffi M
    J Interv Cardiol; 2008 Apr; 21(2):118-21. PubMed ID: 18384343
    [No Abstract]   [Full Text] [Related]  

  • 27. [Role of GP IIb/IIIa blockers in clinical cardiology].
    Rossi ML; Merlini PA
    Recenti Prog Med; 2003 Oct; 94(10):440-3. PubMed ID: 14619191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Rescue" platelet GP IIb/IIIa inhibitor therapy in percutaneous coronary intervention: bailing out of a sunken ship.
    Kandzari DE; Tcheng JE; Harrington RA; Sketch MH
    J Invasive Cardiol; 2000 Oct; 12(10):502-4. PubMed ID: 11022208
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial.
    Bolognese L; Falsini G; Liistro F; Angioli P; Ducci K; Taddei T; Tarducci R; Cosmi F; Baldassarre S; Burali A
    J Am Coll Cardiol; 2006 Feb; 47(3):522-8. PubMed ID: 16458130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients.
    Lavi S; Gruberg L; Kapeliovich M; Hammerman H; Boulos M; Grenadier E; Aronson D; Markiewicz W; Beyar R
    J Invasive Cardiol; 2005 Jun; 17(6):296-9. PubMed ID: 16003002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GP IIb/IIIa inhibitors: an evidence-based approach to their use.
    Med Manag Netw; 1999 Mar; 7(3):5-9. PubMed ID: 10346546
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of early versus late glycoprotein IIb/IIIa inhibitors for PCI.
    Xu Q; Yin J; Si LY
    Int J Cardiol; 2013 Jan; 162(3):210-9. PubMed ID: 22769575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Platelet glycoprotein IIB-IIIA receptor inhibitors in patients with ischemic heart disease].
    Patti G; Fossati C; Manzoli A; D'Ambrosio A; Abbate A; Montesanti R; Di Sciascio G
    Clin Ter; 2000; 151(4):301-6. PubMed ID: 11107681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of glycoprotein IIb/IIIa inhibition in the management of acute coronary syndromes.
    Koller CF
    Heart Lung; 2001; 30(5):321-9; quiz 330-1. PubMed ID: 11604974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplasty].
    Kala P; Poloczek M; Bocek O; Jerábek P; Neugebauer P; Kosová J; Semrád B
    Vnitr Lek; 2002 Aug; 48(8):736-41. PubMed ID: 12425204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoprotein IIb/IIIa inhibitors.
    Lincoff AM
    J Invasive Cardiol; 2004 Jul; 16(7 Suppl):11S-16S. PubMed ID: 23573566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between glycoprotein IIb/IIIa blockade and distal protection device for the restoration of myocardial perfusion during percutaneous coronary intervention for acute myocardial infarction.
    Mak KH; Phay C; Wong A; Kwok V; Tan KS; Lau KW; Koh TH
    J Invasive Cardiol; 2004 Dec; 16(12):694-8. PubMed ID: 15596872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The glycoprotein IIb/IIIa receptor inhibitor (abciximab) in ST-segment elevation myocardial infarction.
    Mesquita A; Baptista J; Palos J; Seabra-Gomes R
    J Invasive Cardiol; 1999 Jun; 11(6):379-82. PubMed ID: 10745556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of glycoprotein IIb/IIIa inhibitors for upstream use in patients with diabetes experiencing unstable angina or non-ST segment elevation myocardial infarction. What have we learned in the last 10 years?
    Silva MA; Gandhi PJ
    J Clin Pharm Ther; 2004 Dec; 29(6):497-510. PubMed ID: 15584937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abciximab: a review and update for clinicians.
    Mazzaferri EL; Young JJ
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):609-18. PubMed ID: 18510478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.